FILTERED RESULTS
FILTERS
Ads Top
•
·
·
FILTERED RESULTS
BOC SURVEY SHOWS ONLY 11% OF FIRMS THINK INFLATION WILL STAY ABOVE 3% FOR THE NEXT TWO YEARS, A...
Cisco (CSCO) Stock Reaches Record Peak as Wall Street Eyes More Upside
Agnico Eagle Just Bought An Entire Gold District — Here's What It's Planning
Potomac Edison Customers in Maryland Can Lower Their Bills With New Residential Time-of-Use Rate
AI Demand Drives Growth for CPU Manufacturers
Projected Global Copper Deficit Expected by 2026 Amid Data Center Growth
Cerebras Systems Files for IPO After Previous Withdrawal
Natera Shares Outperform S&P 500 with Significant Gains
Vadzo Imaging Introduces New NDAA Compliant Industrial Vision Cameras
Tornado Strikes Rivian Factory, No Injuries Reported
Hartford Anticipates Strong Q1 Earnings Driven by Personal Insurance Growth
Charles Schwab Launches Crypto Trading Services
Baker Hughes Anticipates Impact from Weaker Drilling Activity in Q1 Earnings Report
Risks Persist in Private Credit Market Amid Broader Recovery
Nektar Therapeutics Shares Surge Following Positive Alopecia Trial Results
Google Stock Attracts Attention Ahead of Earnings Report
Dividend Stocks Offer Steady Passive Income Amid Inflation
Samsara's Connected Operations Platform Boosts ARR Growth and Customer Retention
President Confirms Strait of Hormuz Will Remain Closed Until Agreement Reached
Vance Remains in the U.S., No Departure to Pakistan Confirmed
US natural gas prices sail higher as investors eye fresh Mideast tensions
Eli Lilly to buy Boston’s Kelonia for up to $7 billion in cancer push
Christine Lagarde: The energy shock: where we stand and what we need to know
BANK OF CANADA'S Q1 BUSINESS OUTLOOK SURVEY, BASED ON AROUND 100 COMPANIES AND MAINLY DONE BEFORE...
QVC Lost the Home Shoppers to Social Media Influencers
What's Happening With Adobe Shares On Monday?
Retail Media Grows but Hard-to-Use Offers Hold It Back
Most Emerging Currencies Slip as Middle East Uncertainty Lingers
IRANIAN OFFICIALS: IRANIAN DELEGATION TO HEAD TO PAKISTAN ON TUESDAY...
Exelon Expected to Mitigate Revenue Impact from PECO Rate Case Withdrawal
Prediction Markets Conference 2026 Set for April in Las Vegas
NextEra Energy Highlights Growth in Power Demand Driven by AI
McKesson Reports Strong Growth in Earnings and Shareholder Value
Target Unveils 2026 Bullseye Builds Initiative to Enhance Community Spaces
Toyota and Honda Form New Manufacturing Alliance in Canada
Who Wins from the Iran Conflict?
Amazon's Partnership with Anthropic Anticipated to Boost Earnings
AST SpaceMobile Shares Decline Following Satellite Launch Issues
Fox Corporation to Host Webcast for Third Quarter Fiscal 2026 Financial Results
Netflix Stock Experiences 9% Decline Following Earnings Guidance
Tesla's Q2 Earnings Call Anticipated Amid FSD Developments
Home Depot Shareholders Propose Governance and ESG Initiatives Ahead of Annual Meeting
Polymarket Seeks $400 Million Funding at $15 Billion Valuation
Taiwan Semiconductor Reports Strong First Quarter Amid AI Growth
Crude Oil Loadings from Yanbu Port Decrease by 17%
Trump Indicates Ceasefire Extension with Iran Unlikely
TSX flat amid renewed U.S.-Iran tensions
Fed Chair nominee Warsh commits to independence, with limits
FRANCE'S MACRON SAYS CMA-CGM SHIP WAS SPECIFICALLY TARGETED....
Novo Nordisk to Seek Approval for Sickle Cell Pill by 2026
Novo Nordisk has announced plans to apply for regulatory approval of its sickle cell disease treatment, etavopivat, in the latter half of 2026. This development marks a significant milestone for the pharmaceutical company as it aims to expand its portfolio in the treatment of sickle cell disease.
In related market news, a competing treatment has experienced a notable decline, with its stock sinking by 24%. This shift highlights the competitive landscape in the sickle cell treatment sector, where advancements and regulatory approvals can significantly impact market dynamics.
Source: KLEA News